Results 141 to 150 of about 2,967,713 (359)

Migraine and Bipolar Disorder

open access: yesJournal of Neurology & Neurophysiology, 2018
The co-morbidity between migraine and bipolar disorders is well documented in numerous clinical and epidemiological studies, but the aetiologies are currently unknown. Many Authors have suggested some pathophysiological mechanisms in common. This co-morbidity, moreover, influences the outcome of both disorders.
Ottavio Di Marco   +2 more
openaire   +2 more sources

Impact of length of stay on diagnostic yield in the epilepsy monitoring unit: A multi‐center retrospective 12‐year Veterans Health Administration study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Epilepsy Monitoring Units (EMUs) in Veterans Health Administration (VHA) Epilepsy Centers of Excellence (ECoE) are critical for the diagnosis and management of seizure disorders. Whether a shorter length of stay (LOS) in the EMU due to scheduling impacts diagnostic yield is unclear.
Maximillian S. Feygin   +40 more
wiley   +1 more source

Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.

open access: yesJournal of Orofacial Pain, 2013
AIMS To investigate the effectiveness of single and concomitant treatment of migraine and temporomandibular disorders (TMD) in women with the comorbidity.
D. Gonçalves   +6 more
semanticscholar   +1 more source

Exploring the symptoms and sleep disorders associated with migraines in women of Syria: A cross‐sectional observational study

open access: yesHealth Science Reports
Background and Aim Migraine is a prevalent neurological disorder characterized by recurring episodes of debilitating headache accompanied by associated symptoms and sleep disorders.
Nafiza Martini   +8 more
doaj   +1 more source

Harnessing Jasminum Bioactive Compounds: Updated Insights for Therapeutic and Food Preservation Innovations

open access: yesFood Frontiers, EarlyView.
Jasminum bioactives improve food preservation by providing antimicrobial and antioxidant effects, especially when incorporated into active packaging, edible films, and nanoformulations that enhance stability and controlled release. They also offer many pharmacological benefits, including anti‐inflammatory, neuroprotective, and wound‐healing properties.
Antonio Rescigno   +17 more
wiley   +1 more source

Exploring the Molecular Pathways Underlying the Anti‐Diabetic Effects of Millets

open access: yesFood Safety and Health, EarlyView.
Millet consumption may modulate gluconeogenesis and glycolysis, enhance glucose transporter activity, increase leptin levels, inhibit the NF‐κB pathway, and mitigate oxidative and nitrosative stress. ABSTRACT Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemic conditions resulting from inadequate insulin production or ...
Akash Kumar   +5 more
wiley   +1 more source

Neurology-as-a-Service for the Developing World [PDF]

open access: yesarXiv, 2017
Electroencephalography (EEG) is an extensively-used and well-studied technique in the field of medical diagnostics and treatment for brain disorders, including epilepsy, migraines, and tumors. The analysis and interpretation of EEGs require physicians to have specialized training, which is not common even among most doctors in the developed world, let ...
arxiv  

Migraine and periodic limb movement disorders in sleep in children: a preliminary case–control study

open access: yesThe Journal of Headache and Pain, 2013
BackgroundThe relationships between sleep and headaches are complex and manifold. About the variety of phenomena that can disrupt the sleep macrostructure and can impact its restorative function, the periodic limb movements disorder (PLMd) can be ...
M. Esposito   +3 more
semanticscholar   +1 more source

Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley   +1 more source

Home - About - Disclaimer - Privacy